Cholesterol Follow-Up Blood Test Panel
- $267.03
- $69.95
- Save: 73.80%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: CK (Total), CPK, CPK (Total), Creatine Kinase CK Total, Creatine Phosphokinase (CPK), Total CK
Creatine Kinase, Total
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
LDL/HDL Ratio
Non HDL Cholesterol
Triglycerides
The Cholesterol Follow-Up Blood Test Panel panel contains 3 tests with 29 biomarkers .
Cholesterol Follow-Up Blood Test Panel
The Cholesterol Follow-Up Blood Test Panel is designed to provide a comprehensive assessment of cardiovascular and metabolic health by analyzing key markers related to cholesterol levels, kidney and liver function, and muscle enzyme activity. This panel is often ordered to monitor lipid levels, assess organ function, and evaluate potential risks associated with heart disease, diabetes, and other metabolic disorders. By examining these biomarkers, healthcare providers can gain valuable insights into a patient's overall health status and make informed decisions regarding treatment, lifestyle modifications, and further diagnostic testing.
When and Why the Cholesterol Follow-Up Blood Test Panel May Be Ordered
This panel is typically ordered for individuals who have been diagnosed with high cholesterol or other cardiovascular risk factors, such as hypertension, diabetes, or a family history of heart disease. It may also be used to monitor patients who are undergoing cholesterol-lowering treatments, such as statins, to ensure that the medication is effectively managing lipid levels without causing adverse effects on liver function or muscle health. In addition, healthcare providers may order this panel for individuals who have experienced unexplained muscle pain, fatigue, or weakness, as certain cholesterol medications can impact muscle enzyme levels. Routine monitoring of kidney and liver function is also crucial, as these organs play essential roles in lipid metabolism and the elimination of waste products from the body.
What the Cholesterol Follow-Up Blood Test Panel Checks For
The Cholesterol Follow-Up Blood Test Panel examines various biomarkers that provide insight into cardiovascular health, metabolic function, and potential medication side effects. Each test in the panel serves a specific purpose in evaluating the patient's overall well-being.
Lipid Profile and Cholesterol Levels
The lipid profile measures total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides. These values help determine the risk of atherosclerosis, a condition characterized by plaque buildup in the arteries, which can lead to heart attacks and strokes. The LDL/HDL ratio provides additional insight into the balance between "bad" and "good" cholesterol, which is essential for assessing cardiovascular risk.
Kidney and Liver Function
Liver and kidney function are evaluated through various metabolic markers. The liver plays a crucial role in cholesterol production and metabolism, while the kidneys help regulate blood pressure and remove waste from the bloodstream. Abnormalities in these functions can indicate underlying health issues that need further investigation.
Muscle Enzyme Activity
Creatine kinase (CK) is an enzyme found in muscle tissue, and elevated levels may indicate muscle damage or inflammation. This is particularly important for patients taking statins or other cholesterol-lowering medications, as these drugs can sometimes cause muscle-related side effects. By analyzing these key biomarkers, healthcare professionals can assess cardiovascular risk, detect metabolic imbalances, and monitor the effects of cholesterol-lowering treatments.
Conditions and Diseases the Cholesterol Follow-Up Blood Test Panel Can Detect
This panel can help diagnose and monitor various conditions related to cardiovascular and metabolic health. Below are some of the primary conditions that can be detected using the Cholesterol Follow-Up Blood Test Panel.
Hyperlipidemia
Hyperlipidemia refers to elevated levels of cholesterol and triglycerides in the blood. High LDL cholesterol increases the risk of atherosclerosis and heart disease, while low HDL cholesterol levels reduce the body's ability to remove excess cholesterol. The lipid panel in this test helps diagnose hyperlipidemia and determine whether dietary changes, lifestyle modifications, or medication are needed.
Atherosclerosis
Atherosclerosis occurs when cholesterol and other substances accumulate in the arteries, forming plaques that can restrict blood flow. Over time, this condition can lead to serious cardiovascular events, such as heart attacks and strokes. The lipid panel provides essential data on cholesterol levels and helps identify individuals at risk for developing atherosclerosis.
Liver Disease
The liver plays a central role in cholesterol metabolism. Conditions such as fatty liver disease, hepatitis, or liver dysfunction can disrupt cholesterol levels and impact overall metabolic health. Abnormal metabolic panel results may indicate liver disease, prompting further testing and evaluation.
Kidney Disease
Kidney function is closely linked to cardiovascular health, as the kidneys help regulate blood pressure and remove waste from the body. Impaired kidney function can contribute to hypertension and cardiovascular disease. The metabolic panel helps assess kidney health and detect early signs of kidney disease.
Statin-Induced Myopathy
Statins, which are commonly prescribed to lower cholesterol levels, can sometimes cause muscle pain, weakness, or damage, a condition known as statin-induced myopathy. Elevated creatine kinase levels in the blood suggest muscle injury and may indicate the need for medication adjustments or alternative treatments. By identifying these conditions early, healthcare providers can implement appropriate interventions to reduce health risks and improve patient outcomes.
How Healthcare Professionals Use the Cholesterol Follow-Up Blood Test Panel in Treatment and Monitoring
Healthcare providers use the results of the Cholesterol Follow-Up Blood Test Panel to guide treatment decisions and monitor patients with metabolic and cardiovascular conditions. Below is an explanation of how these results inform clinical care for each condition.
Managing Hyperlipidemia
For patients diagnosed with hyperlipidemia, healthcare professionals use lipid panel results to determine whether dietary changes, exercise, or cholesterol-lowering medications are necessary. If cholesterol levels remain high despite lifestyle modifications, medications such as statins may be prescribed to help reduce LDL cholesterol and triglycerides.
Preventing Atherosclerosis
If the test results indicate a high risk of atherosclerosis, doctors may recommend aggressive lifestyle changes, such as adopting a heart-healthy diet, increasing physical activity, and quitting smoking. In cases where medication is necessary, lipid-lowering drugs can be prescribed to slow the progression of arterial plaque buildup.
Monitoring Liver Disease
Abnormal metabolic panel results suggest potential liver dysfunction, prompting further evaluation. If liver disease is confirmed, treatment strategies may include lifestyle modifications, medication management, or addressing underlying causes such as alcohol consumption, obesity, or viral infections.
Detecting Kidney Disease
If kidney function markers indicate potential kidney disease, healthcare providers may order additional tests to assess renal function more comprehensively. Treatment strategies often include blood pressure control, dietary adjustments, and medications to prevent further kidney damage.
Assessing Statin-Induced Myopathy
Patients taking statins who experience muscle pain or weakness may have their creatine kinase levels monitored to assess muscle damage. If elevated CK levels are detected, the healthcare provider may adjust the medication dosage, switch to an alternative cholesterol-lowering drug, or recommend lifestyle changes to alleviate symptoms. By regularly monitoring these biomarkers, healthcare professionals can adjust treatment plans as needed, ensuring optimal management of cardiovascular and metabolic health.
Conclusion
The Cholesterol Follow-Up Blood Test Panel is an essential tool for assessing and monitoring cardiovascular and metabolic health. By evaluating lipid levels, organ function, and muscle enzyme activity, this panel provides valuable insights into conditions such as hyperlipidemia, atherosclerosis, liver disease, kidney disease, and statin-induced myopathy. The results help healthcare providers make informed decisions about lifestyle interventions, medication management, and further diagnostic testing. Regular monitoring through this panel can help prevent complications, improve health outcomes, and support long-term cardiovascular wellness.